SLC25A22 and colorectal carcinoma: Due to its high sensitivity and reproducibility, LC-MS-based metabolomics is a promising strategy to further elucidate metabolic pathways regulated by SLC25A22 in KRAS-mutant CRC and provide insights into the therapy of CRC with KRAS mutation.